| RS183191346 |
DYNC2H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Jeune thoracic dystrophy |
| RS183191959 |
FAT4
|
Health Risk |
Conflicting classifications of pathogenicity |
FAT4-related disorder, FAT4-related disorder |
| RS183195890 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS183197573 |
CNGA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS183204825 |
ITGB2
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS183204936 |
SGCG
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, Sarcoglycanopathy |
| RS183208638 |
PGAP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperphosphatasia with intellectual disability syndrome 4, Hyperphosphatasia with intellectual disability syndrome 4 |
| RS183208875 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS183214630 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 2, ABCB11-related disorder |
| RS183218622 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Alport syndrome, Alport syndrome |
| RS1832192414 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Inborn genetic diseases |
| RS1832200861 |
DBH
|
Health Risk |
Conflicting classifications of pathogenicity |
Orthostatic hypotension 1, Inborn genetic diseases |
| RS183220684 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1832230836 |
COQ4
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS183223259 |
VCP
|
Health Risk |
Conflicting classifications of pathogenicity |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 6, Inclusion body myopathy with Paget disease of bone and frontotemporal dementia |
| RS183230983 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5B, with muscular dystrophy |
| RS1832340912 |
NR5A1
|
Health Risk |
Pathogenic |
Oligosynaptic infertility, 46 |
| RS183238138 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS183238369 |
XPC
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum, group C |
| RS1832447335 |
NR5A1
|
Health Risk |
Pathogenic |
46, XX sex reversal 4 |
| RS1832448970 |
COQ4
|
Health Risk |
Pathogenic |
Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome, Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome |
| RS1832453675 |
ABCA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS183245562 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1832456567 |
NR5A1
|
Health Risk |
Pathogenic |
Oligosynaptic infertility, 46 |
| RS1832458239 |
NR5A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Genetic non-acquired premature ovarian failure, 46 |
| RS183247300 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS1832493257 |
NR5A1
|
Health Risk |
Pathogenic |
Oligosynaptic infertility, 46 |
| RS1832494273 |
NR5A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Oligosynaptic infertility, 46 |
| RS1832496555 |
NR5A1
|
Health Risk |
Likely pathogenic |
— |
| RS1832496590 |
NR5A1
|
Health Risk |
Likely pathogenic |
46, XY sex reversal 3 |
| RS1832499155 |
GRIN1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS183251531 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
RAI1-related disorder, RAI1-related disorder |
| RS183252158 |
CERKL
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS183254966 |
ALDH7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS183255090 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS183256997 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 3, MYO15A-related disorder |
| RS1832583187 |
RELN
|
Health Risk |
Pathogenic |
Familial temporal lobe epilepsy 7, Norman-Roberts syndrome |
| RS183258549 |
PTPRQ
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 84A, Autosomal recessive nonsyndromic hearing loss 84A |
| RS183258737 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS183261121 |
DNAH14
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS183261547 |
LCA5
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS1832615643 |
VPS13A
|
Health Risk |
Likely pathogenic |
— |
| RS1832615773 |
VPS13A
|
Health Risk |
Likely pathogenic |
— |
| RS1832616472 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS183261797 |
IFT140
|
Health Risk |
Conflicting classifications of pathogenicity |
Saldino-Mainzer syndrome, Retinitis pigmentosa 80 |
| RS183262122 |
LAMA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1JJ |
| RS183263185 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1832680700 |
GATA3
|
Health Risk |
Pathogenic |
Hypoparathyroidism, deafness |
| RS1832681636 |
COL27A1
|
Health Risk |
Pathogenic |
— |
| RS1832691674 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS1832698457 |
GATA3
|
Health Risk |
Pathogenic |
Hypoparathyroidism, deafness |
| RS1832712113 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS183272965 |
SELENON
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myopathy with fiber type disproportion, Eichsfeld type congenital muscular dystrophy |
| RS1832756019 |
SLC27A4
|
Health Risk |
Likely pathogenic |
— |
| RS183276016 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS183276533 |
MICAL1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1832767186 |
SLC27A4
|
Health Risk |
Pathogenic |
— |
| RS183276875 |
ASS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Citrullinemia type I, Citrullinemia |
| RS183278868 |
TTN
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1832802732 |
SLC27A4
|
Health Risk |
Likely pathogenic |
Lamellar ichthyosis, Lamellar ichthyosis |
| RS183280626 |
GABRA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 19 |
| RS1832811905 |
COL27A1
|
Health Risk |
Likely pathogenic |
— |
| RS1832838063 |
KCNT1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 14 |
| RS183284555 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Neuropathy |
| RS183285809 |
TJP2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1832871459 |
LARP4B
|
Health Risk |
association |
Autism spectrum disorder, Autism spectrum disorder |
| RS183288709 |
NDUFA13
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1832898282 |
GATA3
|
Health Risk |
Pathogenic |
Hypoparathyroidism, deafness |
| RS1832899364 |
GATA3
|
Health Risk |
Pathogenic |
Congenital anomaly of kidney and urinary tract, Hypoparathyroidism |
| RS183296277 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS1832966881 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1832979860 |
RELN
|
Health Risk |
Pathogenic |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS1832998425 |
INVS
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Infantile nephronophthisis |
| RS1833004339 |
INVS
|
Health Risk |
Pathogenic |
Nephronophthisis, Infantile nephronophthisis |
| RS183301169 |
HOGA1
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS183302003 |
TRIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1833029885 |
SEPHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
VERVERI-BRADY SYNDROME 2, SEPHS1-related developmental delay |
| RS1833052702 |
FOCAD
|
Health Risk |
Pathogenic |
Liver disease, severe congenital |
| RS183306159 |
TRPM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial heart block type IB, Erythrokeratodermia variabilis et progressiva 6 |
| RS1833089251 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1833092121 |
VPS13B
|
Health Risk |
Pathogenic/Likely pathogenic |
Abnormality of the nervous system, Cohen syndrome |
| RS183309645 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1833108141 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS183312399 |
CCDC88C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hydrocephalus, nonsyndromic |
| RS183316447 |
KNL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 4, primary |
| RS183318466 |
RHO
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness autosomal dominant 1, Congenital stationary night blindness autosomal dominant 1 |
| RS183319660 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS183319966 |
CCDC88C
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS183322775 |
CARD14
|
Health Risk |
Conflicting classifications of pathogenicity |
Psoriasis 2, Pityriasis rubra pilaris |
| RS183322816 |
B3GLCT
|
Health Risk |
Conflicting classifications of pathogenicity |
Peters plus syndrome, Peters plus syndrome |
| RS1833240016 |
CARD9
|
Health Risk |
Pathogenic |
Predisposition to invasive fungal disease due to CARD9 deficiency, Predisposition to invasive fungal disease due to CARD9 deficiency |
| RS1833255504 |
COL5A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1833258579 |
COL5A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1833261804 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS183328334 |
FRAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 1, FRAS1-related disorder |
| RS183328495 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS183330533 |
ANK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1833331932 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS183333679 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1833357461 |
GRIN1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |